|
|
||||||||
Department of Medicine and the Gazes Cardiac Research Institute, Medical University of South Carolina, and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina 29403
| |
ABSTRACT |
|---|
|
|
|---|
This study examined how translational mechanisms regulate the rate of cardiac protein synthesis during canine pressure overload in vivo. Acute aortic stenosis (AS) was produced by inflating a balloon catheter in the ascending aorta for 6 h; sustained AS was created by controlled banding of the ascending aorta. AS caused significant hypertrophy as reflected by increased left ventricular (LV) mass after 5 and 10 days. To monitor LV protein synthesis in vivo, myosin heavy chain (MHC) synthesis was measured by continuous infusion of radiolabeled leucine. Acute AS accelerated the rate of myosin synthesis without a corresponding increase in ribosomal RNA, indicating an increase in translational efficiency. Total MHC synthesis (mg MHC/LV per day) was significantly increased at 5 and 10 days of sustained AS. Total MHC degradation was not significantly altered at 5 days of AS but increased at 10 days of AS in concordance with a new steady state with respect to growth. Translational capacity (mg total RNA/LV) was significantly increased after 5 and 10 days of AS and was preceded by an increase in the rate of ribosome formation. MHC mRNA levels remained unchanged during AS. These findings demonstrate that cardiac protein synthesis is accelerated in response to pressure overload by an initial increase in translational efficiency, followed by an adaptive increase in translational capacity during sustained hypertrophic growth.
pressure overload; translation; eukaryotic initiation factor 4E
| |
INTRODUCTION |
|---|
|
|
|---|
HYPERTROPHY is the primary mechanism by which the adult myocardium compensates for hemodynamic overload (10). Hypertrophy is thought to be initiated by an increase in myocardial wall stress as defined by the Laplace equation in which wall stress is calculated as (pressure × radius)/(2 × wall thickness) (13). It has been postulated that, in pressure overload, the increase in pressure in the numerator of the equation increases systolic wall stress, thereby initiating the development of concentric hypertrophy and increasing the thickness of the myocardial wall. This increase in wall thickness offsets the increase in systolic pressure and maintains wall stress within the normal range. In volume overload, increased diastolic stress is thought to trigger the development of eccentric hypertrophy in which lengthening of the cardiac muscle cells leads to chamber enlargement.
The myocardial proteins are in a constant dynamic state of synthesis and degradation when the myocardium is in a steady state with respect to growth (31). For hypertrophy to occur, the net balance between protein synthesis and protein degradation must be altered, by either accelerating the rate of protein synthesis or decreasing the rate of protein degradation. In the volume overload of mitral regurgitation, we have shown that the rate of protein synthesis was not accelerated and that hypertrophic growth was attributable to a decrease in the rate of protein degradation (24). The amount of hypertrophy produced by volume overload is generally less than that produced by pressure overload (5). In contrast, our study of acute aortic stenosis (AS) showed a marked acceleration of the rate of protein synthesis, which occurred without an increase in either the ribosomal RNA pool or in mRNA levels (17). This response to acute pressure overload is indicative of an increase in translational efficiency, defined as the utilization of the mRNA pool by the preexisting translational machinery in the adult myocardium. Similar increases in efficiency have been observed in other models of pressure overload (9, 27, 32). Translational mechanisms are also known to have a central role in accelerating protein synthesis rates during sustained pressure overload. During the growth phase of pressure-overload hypertrophy, there is a well-established increase in the capacity for protein synthesis as defined by the amount of translational machinery, including ribosomes, tRNA, and initiation and elongation factors (31). However, the precise roles of translational efficiency and capacity in controlling the hypertrophic process in pressure overload have never been studied in a unified fashion from the initiation of hypertrophy to the achievement of a new steady state in a large animal model of gradual stenosis such as that seen in humans.
We have recently developed a canine model of aortic stenosis in which pressure overload is controlled by an externally controlled aortic band (23). After an increase in stenosis severity, there is a detectable increase in cardiac mass by 24 h, followed by linear growth that reaches a new steady state in 10 days. We hypothesized that the role of translational efficiency is to accelerate the rate of protein synthesis in response to the initial increase in systolic wall stress, whereas the role of capacity is to produce an overall increase in translational machinery and thereby maintain accelerated protein synthesis rates during sustained hypertrophic growth. The rate of myosin heavy chain (MHC) synthesis was used as a specific marker of protein synthesis in vivo. The hypothesis was tested by examining translational regulation in the canine left ventricle (LV) at three phases of pressure overload: the acute phase (6 h), the rapid growth phase (5 days), and the steady-state phase of hypertrophy (10 days). To determine the linkage between increased systolic wall stress and accelerated rates of cardiac protein synthesis, two key mechanisms for increasing translational efficiency and capacity were examined: 1) changes in the activity of eukaryotic initiation factor 4E (eIF4E) as measured by its phosphorylation and 2) changes in the rate of 60S ribosome formation and net accumulation of rRNA.
| |
METHODS |
|---|
|
|
|---|
Models of canine pressure overload.
All procedures were done in accordance to institutional guidelines.
Five adult mongrel dogs were used as controls. Anesthesia was induced
with an infusion of 0.15 mg · kg
1 · min
1
sufentanil supplemented by isoflurane and maintained by a constant infusion of sufentanil and a low dose of isoflurane by inhalation. A
thermodilution Swan-Ganz catheter was inserted via the femoral vein for
measuring pulmonary capillary wedge pressure, pulmonary artery
pressure, and cardiac output. A second catheter was placed in the
femoral artery for measuring arterial blood pressure.
0.226 + 0.984x
(R = 0.96), where
y is the LV mass determined by
ventriculography and x is the actual LV mass (4). Total stroke volume was quantified by contrast left
ventriculography and thermodilution cardiac output.
Continuous infusion of radiolabeled leucine. Hearts were radiolabeled by continuous infusion with L-[3,4,5-3H(N)]leucine over 6 h as described previously (24). In the acute AS experiments, infusion was begun as soon as the hemodynamic conditions were stable. Blood samples were withdrawn from the ascending aorta at regular intervals for measurement of plasma leucine-specific radioactivity. When the infusion period was completed, the hearts were rapidly removed and rinsed in ice-cold saline, and the great vessels were perfused retrogradely with ice-cold saline. For measurements of the rate of ribosome formation, portions of the LV free wall were minced and homogenized immediately. The remaining heart tissue was frozen in liquid nitrogen and stored. Samples of frozen LV and RV free wall were used to measure the rate of MHC synthesis, MHC mRNA levels, MHC content, and total RNA content.
Determination of plasma leucine-specific radioactivity. Blood samples were centrifuged, and perchloric acid (PCA) was added to a final concentration of 6%. The plasma proteins were pelleted by centrifugation. The supernatant was neutralized by addition of KOH, centrifuged, and dried by vacuum centrifugation. The sample was resuspended in 0.1 M NaHCO3-Na2CO3 buffer, pH 9.5, and reacted with an equal volume of 5 mM [14C-methyl]dansyl chloride (110-120 mCi/mmol) at 37°C for 1 h. The dansylated amino acids were purified by two-dimensional thin-layer chromatography on micropolyamide plates as described previously (1). The 3H-to-14C ratio of the dansyl-leucine spot was used to calculate the plasma leucine-specific radioactivity.
Determination of MHC synthesis rates.
The fractional rate of MHC synthesis
(Ks) was
determined by the continuous infusion method using the following
formula
|
F*dt is the
plasma leucine-specific radioactivity time curve. MHC was purified as
described previously (17) and the specific radioactivity of leucine in
MHC was measured by the dansyl-chloride method.
Measurement of rate of ribosome formation. The rate of 60S ribosome formation was determined by measuring the rate of incorporation of [3H]leucine into protein of purified 60S ribosomes and dividing by the specific radioactivity of the plasma leucine pool (24, 37). Rates of 60S ribosome formation were calculated using the following formula
|
Measurement of RNA content, total protein content, and MHC content. Total RNA content in the supernatant was determined spectrophotometrically at a wavelength of 260 nm as described previously (37). For measuring total protein content, the residual pellet was washed three times with 0.2 N PCA, resuspended with 0.3 N NaOH, and incubated at 37°C overnight. The concentration of total protein content was measured by the bicinchoninic acid method (Pierce, Rockford, IL). MHC content was measured as described previously (24).
Determination of MHC mRNA levels. RNA was extracted using the guanidinium thiocyanate method (8). Slot-blot hybridization analysis was carried out using a 32P-labeled feline MHC cDNA probe as described previously (24). The autoradiograms were analyzed by digital image analysis using NIH Image software. The optical densities of the hybridization signals were in the linear range.
Measurement of eIF4E phosphorylation.
Portions of frozen LV (100 mg) were homogenized in lysis
cell buffer (LCB) [20 mM HEPES, pH 7.5, 100 mM KCl, 0.2 mM EDTA, 7 mM
-mercaptoethanol, 10% (vol/vol) glycerol, 0.5% (vol/vol) Triton X-100, 80 mM 2-glycerophosphate, 50 mM NaF, 0.2 mM
phenylmethylsulfonyl fluoride, 1 mM benzamidine, 0.5 mM sodium
orthovanadate, 1 µM okadaic acid, 1 µM microcystin LR, 25 µg/ml
leupeptin, 2 U/ml aprotinin, and 20 µg/ml chymostatin] and
centrifuged at 12,000 g for 10 min.
Twenty microliters of washed
m7GTP-Sepharose 4B (Pharmacia)
were added to the supernatant and incubated for 1 h at 4°C. The
m7GTP-Sepharose was pelleted and
washed three times with LCB. The phosphorylation state of eIF4E was
determined by vertical slab gel isoelectric focusing and Western
blotting as described previously (40). The percentage of phosphorylated
eIF4E was quantified by digital image analysis.
| |
RESULTS |
|---|
|
|
|---|
Hemodynamics of experimental pressure overload.
In Table 1, hemodynamic data for the
control and AS dogs are shown. Hemodynamic measurements were taken at
hourly intervals during continuous infusion and averaged. Heart rate
was increased as a result of pacemaker implementation to ~100
beats/min and was maintained over the duration of AS. Systolic and
diastolic blood pressure were significantly lower during the acute AS
procedure but were normal as measured after 5 and 10 days of sustained
AS. The severity of pressure overload was demonstrated by a significant 60% increase in LV systolic pressure in the acute AS model and increases of 75% and 72% after 5 and 10 days of AS, respectively. Pulmonary capillary wedge pressure was significantly increased but
remained within the normal range for our laboratory. Pulmonary artery
systolic pressure was increased by an average of 17%, but these
increases were not statistically different compared with controls.
Stroke volume was decreased significantly at 5 days of AS but increased
toward the control value by 10 days of AS, indicating that the LV
compensated for the sustained increase in afterload. Table 1 also shows
that there were no significant differences in body weight between
control and AS dogs at any experimental time point.
|
Development of pressure-overload hypertrophy.
Changes in LV mass were determined by ventriculography. The baseline
value for LV mass was measured in each dog before the increase in
pressure gradient. As shown in Fig. 1, LV
mass was significantly increased by 11.1% and 26.4% after 5 and 10 days of AS, respectively. There were corresponding increases in the LV
mass-to-body weight ratio of 15.1% and 28.1%, confirming that compensatory LV hypertrophy occurred in response to sustained pressure
overload. Body weight did not change from baseline values during
experimental AS, indicating that the adult dogs were in a steady state
with respect to growth (23.1 ± 1.0 kg at baseline vs. 22.9 ± 1.3 kg after 5 days of AS; 21.2 ± 1.0 kg at baseline vs. 21.5 ± 1.1 kg after 10 days of AS).
|
Specific radioactivity of precursor pool during continuous infusion.
Plasma leucine-specific radioactivity equilibrates with
leucyl-tRNA-specific radioactivity in the canine LV during continuous infusion (17) and was therefore used as the precursor pool for calculating the rate of MHC synthesis and the rate of 60S ribosome formation. Figure 2 shows the plasma
leucine-specific radioactivity time curve during 6 h of continuous
infusion with
[3H]leucine in control
and AS dogs. In each experimental group, the plasma leucine-specific
radioactivity rose rapidly during the first 30 min and plateaued to a
constant value over the remainder of the infusion period. There were no
significant differences in plasma leucine-specific radioactivity in the
control dogs compared with any of the AS groups.
|
Effect of pressure overload on rate of protein synthesis.
The anabolic effects of AS on cardiac protein synthesis were determined
by measuring Ks.
Figure 3A
shows that MHC Ks
was significantly increased by 29% in response to acute pressure
overload compared with control. MHC
Ks decreased
after 5 days of pressure overload and slowed to the control value by 10 days. In Fig. 3B, the rate of total
MHC synthesis after 5 and 10 days of AS was calculated by multiplying
Ks (%/day) by
the corresponding value for total MHC content per LV [(mg MHC/g
LV protein) × g LV]. This calculation takes into account
the increase in LV mass that occurs during pressure-overload
hypertrophy. Accordingly, the rate of total MHC synthesis was increased
by 87% and 63% after 5 and 10 days of AS, respectively.
|
Effect of pressure overload on rate of protein degradation.
The fractional rate of MHC degradation
(Kd) can be
calculated indirectly using the formula
Kg = Ks
Kd, where
Kg is the
fractional rate of MHC accumulation. We calculated MHC
Kd at 5 days of
AS because prior studies using serial echocardiography showed that LV
hypertrophy in the AS dogs occurred as a linear function over the first
9 days (23). Kg
was determined at the 5-day time point by fitting growth to a linear
function and dividing the rate of growth (g LV/day) by the
corresponding value for LV mass (g). The
Kg value derived
from LV mass was substituted for MHC
Kg because MHC
protein as a fraction of total LV protein remained constant. The
calculated MHC Kd
after 5 days of AS was 1.14%/day, a value lower than the control value
of 2.63%/day. Thus, whereas MHC
Ks was increased
during the growth phase of AS-induced hypertrophy, MHC
Kd was decreased.
The rate of total MHC degradation, calculated by multiplying
Kd by total MHC
content per LV, was decreased after 5 days of AS, but it was not
significantly different from that in the control (Fig.
3B). LV growth reached a plateau
after 10 days of AS, which is indicative of a new steady state (23). Accordingly, Fig. 3B shows that MHC
degradation increased and became equivalent to MHC synthesis after 10 days of AS.
Capacity for protein synthesis during pressure-overload hypertrophy.
Total RNA content is a well-described marker for changes in
translational capacity of cardiac muscle because ribosomal RNA is
~85% of the total RNA pool. Figure
4A shows
that RNA content normalized to total protein increased after 5 days of
AS and that the increase was maintained at 10 days of AS. In Fig.
4B, the overall increase in
translational capacity during hypertrophic growth was calculated by
multiplying RNA content (mg RNA/g LV protein) by the corresponding
values for LV mass (g). Pressure overload caused a sustained increase
in capacity as indicated by a 64% and 71% increase in RNA content per
LV after 5 and 10 days of AS, respectively. To determine the mechanism
for rRNA accumulation, the rate of 60S ribosome formation was measured during pressure-overload hypertrophy (Fig.
4C). The rate of ribosome formation
was significantly accelerated in response to acute AS but returned to
the control value after 5 days. Given that the half-life of the
ribosome is ~10-12 days, these data suggest that the early
increase in ribosome formation accounted for the accumulation in RNA
content that occurred by 5 days of pressure-overload hypertrophy.
|
Efficiency of protein synthesis during pressure-overload
hypertrophy.
Translational efficiency is defined as the rate of protein synthesis
normalized to the amount of translational machinery, in particular, the
ribosome pool (31). To calculate translational efficiency, the rate of
MHC synthesis at each time point of AS was divided by total RNA content
(Fig.
5A).
These data show that translational efficiency was increased in response
to acute AS because the rate of MHC synthesis was accelerated before an
increase in RNA content. Figure 5A
also shows that translational efficiency progressively decreased after
5 and 10 days of AS in association with a corresponding increase in
translational capacity. These data indicate that once the increase in
capacity has occurred, steady-state levels of translational efficiency
are sufficient to maintain the accelerated rate of total MHC synthesis
in the hypertrophied LV.
|
-MHC cDNA probe. The blots were then
stripped and hybridized with a 28S rDNA probe. The data for all dogs
were summarized in Fig. 5C by
normalizing the MHC mRNA-to-28S rRNA ratio in the LV to the
corresponding ratio measured in the companion RV of each heart, which
is normally loaded and serves as an internal control. These data show
that MHC mRNA levels relative to 28S rRNA did not change significantly
at any time point in the AS dogs and that the rate of MHC synthesis was
accelerated during acute AS without a corresponding increase in the
relative abundance of the MHC mRNA pool. Although there was not a
selective induction of MHC mRNA during chronic AS, the overall size of
the MHC mRNA pool in the LV increased because of the corresponding
increase in total RNA per LV (see Fig. 4). These data are consistent
with the high levels of efficiency observed in response to acute AS and
with the return to steady-state levels of efficiency as the MHC mRNA
and ribosome pools expand coordinately during hypertrophic growth.
Effect of pressure overload on eIF4E activity.
eIF4E is involved in controlling the binding of mRNA to the 40S
ribosomal subunit, a rate-limiting step during the process of
translational initiation. Phosphorylation of eIF4E enhances its
affinity for the 7-methylguanosine cap on the mRNA molecules. In Fig.
6, phosphorylation of eIF4E in canine LV
was used as a marker to assess changes in the activity of eIF4E. Acute
AS increased the extent of eIF4E phosphorylation to 24% compared with
8% in the LV of controls, and this increase was maintained during
sustained pressure overload. These findings suggest that eIF4E activity as measured by phosphorylation correlated with the initial increase in
translational efficiency and that eIF4E activity remained elevated as
translational capacity increased during pressure-overload hypertrophy. The relative amount of eIF4E protein, normalized to total LV protein, did not change during pressure-overload hypertrophy (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
A direct comparison between pressure and volume overload suggests that increased wall stress particular to each type of mechanical overload is the primary determinant of the hypertrophic phenotype (5, 13). In the case of LV pressure-overload hypertrophy, the molecular basis for altering the phenotype can be found in two distinct processes. The first is increased expression of specific mRNAs encoding proteins that directly affect cardiac growth and function. These include diverse classes of proteins such as transcription factors (20), growth factors (3), tubulin (38), and fetal isoforms of the myofibrillar proteins myosin and actin (7). The second process involves acceleration of the rate of protein synthesis to produce an overall increase in LV mass (31). The resultant hypertrophy of the individual cardiac muscle cells is characterized by increases in constitutively expressed proteins such as myosin and actin. The interplay of these two processes during hypertrophy enables plasticity of the cardiac phenotype in the setting of a compensatory increase in LV mass.
With the use of MHC as a specific marker of cardiac protein synthesis in vivo, MHC synthesis was accelerated by pressure overload without any measurable changes in MHC mRNA abundance. This study shows that translational mechanisms coordinately accelerate the rate of protein synthesis during pressure-overload hypertrophy. The role of translational efficiency is to accelerate the rate of protein synthesis in response to the initial increase in systolic wall stress, whereas the role of capacity is to maintain accelerated rates of protein synthesis during hypertrophic growth, thereby producing a new steady state. The efficiency of protein synthesis in adult myocardium is quite high even during steady-state conditions; ~80% of the ribosome pool can be found in the actively translating 80 S and polysome fractions (30, 31). Thus the potential to accelerate the rate of protein synthesis during sustained hypertrophic growth is limited. A new steady-state protein synthesis rate can be maintained in the hypertrophied myocardium via the combination of its normally high levels of efficiency and the increase in translational capacity. This conclusion is supported by the data in Fig. 3B showing that total MHC synthesis rates are maintained at a higher steady-state value during sustained pressure-overload hypertrophy, even though efficiency has returned to the control level.
Previous studies have established a role for translational efficiency in accelerating protein synthesis in response to pressure overload in vivo (17, 27, 32). An increase in efficiency likewise accelerated the rate of protein synthesis when adult cardiac muscle cells in vitro were subjected to acute increases in load, in the form of either electrically stimulated contraction or passive stretch on a deformable membrane (18, 19, 22). The translational efficiency of protein synthesis is usually determined by the rate-limiting reactions governing peptide chain initiation, and efficiency can be improved by increasing the activity of initiation factors (16). In the process of translational initiation, binding of eIF4E to the 7-methylguanosine cap of mRNA is required for the translationally active eIF4F complex to perform its functions of unwinding mRNA secondary structure and promoting binding of mRNA to the 40S ribosomal subunit. Phosphorylation of eIF4E on the serine-209 residue increases binding affinity for the 7-methylguanosine cap present on virtually all mRNA molecules and stabilizes the translationally active eIF4F complex (2, 21, 28). The positive correlation between pressure overload and eIF4E phosphorylation is a potential mechanism for increasing efficiency of protein synthesis in the cardiac muscle cell. Our previous studies showed that acute pressure overloading of the LV produced by AS increased eIF4E phosphorylation but that acute volume overload of the LV did not stimulate eIF4E phosphorylation (40). The present studies show that the acute increase in eIF4E phosphorylation was sustained during chronic AS and suggest that eIF4E phosphorylation may have several roles in regulating the rate of protein synthesis during pressure-overload hypertrophy. Initially, eIF4E phosphorylation may increase translational efficiency in response to acute pressure overload. The persistent increase in eIF4E phosphorylation during chronic AS may serve the function of maintaining steady-state levels of translational efficiency as the capacity increases during sustained hypertrophic growth.
The acceleration of MHC synthesis in response to pressure overload did
not involve selective upregulation of MHC mRNA levels in the canine
myocardium. Rather, the MHC mRNA pool increased in proportion to the
ribosome pool during hypertrophic growth. These observations underscore
an important distinction between changes in the relative expression of
- and
-MHC mRNA isoforms that occur in rodent models of
pressure-overload hypertrophy and actual net increases in the total MHC
mRNA levels. It is well established that transcriptional and
posttranscriptional mechanisms control expression of MHC isoforms
during pressure-overload hypertrophy in rats via alterations in the
relative abundance of the corresponding MHC mRNA (6, 15, 29, 34).
However, there is no shift in MHC isoform composition during
hypertrophy of the canine LV because
-MHC is constitutively
expressed as the predominant isoform, similar to other large mammalian
species, including humans (39). To our knowledge, there are no data
employing any large mammalian model of LV hypertrophy proving that the
overall rate of MHC synthesis is controlled by selectively increasing
the size of the MHC mRNA pool. A recent study (41) showed that banding
of the ascending aorta in adult rats produced hypertrophy without an
increase in
-MHC mRNA levels, yet expression of
-MHC protein was
increased. This study also revealed that selective increases in
-MHC
mRNA levels after constriction of the abdominal aorta proximal to the renal arteries may result from activation of the renin-angiotensin system, suggesting that
-MHC mRNA expression can be dissociated from
the increase in MHC synthesis that occurs in response to pressure
overload. Thus the mechanical stimulus of pressure overload produced by
constriction of the ascending aorta in either rat or dog is apparently
sufficient to produce LV hypertrophy and demonstrates that selective
induction of
-MHC mRNA is not required to accelerate the rate of MHC synthesis.
Sustained pressure overload triggered an increase in total RNA content, a standard index of the translational capacity in adult myocardium. The accumulation of RNA was attributable to an increase in the rate of ribosome formation that occurred after 6 h of pressure overload. It has been shown that cardiac muscle can increase capacity in response to load by altering one or more of the reactions involved in ribosome formation (9, 37). For example, the onset of pressure overload in vivo increased 28S rRNA synthesis (36) and the activity of RNA polymerase I, the enzyme that transcribes rDNA (12). These observations were confirmed using neonatal rat myocytes in vitro (25, 26). More recent findings (14) suggest that capacity is increased during growth of neonatal rat myocytes via the activity of UBF, a DNA binding protein that regulates transcription of the rDNA genes.
We conclude that translational mechanisms coordinately regulate the rate of protein synthesis during hypertrophy induced by a stepwise increase in LV pressure overload. The rate of protein synthesis is accelerated by an increase in translational efficiency and is maintained at a higher steady state by an adaptive increase in translational capacity during sustained hypertrophic growth.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Gilberto DeFreyte for excellent technical assistance.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant P01-HL-48788 and the Research Service of the Department of Veterans Affairs.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: P. J. McDermott, Gazes Cardiac Research Institute, Rm. 303, Strom Thurmond Biomedical Research Bldg., 114 Doughty St., Charleston, SC 29403 (E-mail: mcdermp{at}musc.edu).
Received 8 February 1999; accepted in final form 17 June 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Airhart, J.,
S. Sibiga,
H. Sanders,
and
E. A. Khairallah.
An ultramicro method for quantification of amino acids in biologic fluids.
Anal. Biochem.
53:
132-140,
1973[Medline].
2.
Bu, X.,
D. W. Haas,
and
C. H. Hagedorn.
Novel phosphorylation sites of eukaryotic initiation factor-4F and evidence that phosphorylation stabilizes interactions of the p25 and p220 subunits.
J. Biol. Chem.
268:
4975-4978,
1993
3.
Calderone, A.,
N. Takahashi,
N. J. Izzo,
C. M. Thaik,
and
W. S. Colucci.
Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs.
Circulation
92:
2385-2390,
1995
4.
Carabello, B. A.,
K. Nakano,
W. Corin,
R. Biederman,
and
J. F. Spann, Jr.
Left ventricular function in experimental volume overload hypertrophy.
Am. J. Physiol.
256 (Heart Circ. Physiol. 25):
H974-H981,
1989
5.
Carabello, B. A.,
M. R. Zile,
R. Tanaka,
and
G. Cooper IV.
Left ventricular hypertrophy due to volume overload versus pressure overload.
Am. J. Physiol.
263 (Heart Circ. Physiol. 32):
H1137-H1144,
1992
6.
Chassagne, C.,
C. Wisnewsky,
and
K. Schwartz.
Antithetical accumulation of myosin heavy chain but not
-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy.
Circ. Res.
72:
857-864,
1993
7.
Chien, K. R.,
Z. Hong,
K. U. Knowlton,
W. Miller-Hance,
M. van-Bilson,
T. X. O'Brien,
and
S. M. Evans.
Transcriptional regulation during cardiac growth and development.
Annu. Rev. Physiol.
55:
77-95,
1993[Medline].
8.
Chirgwin, J. M.,
A. E. Przybyla,
R. J. MacDonald,
and
W. J. Rutter.
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
Biochemistry
18:
5294-5299,
1979[Medline].
9.
Chua, B. H. L.,
L. A. Russo,
E. E. Gordon,
B. J. Kleinhans,
and
H. E. Morgan.
Faster ribosome synthesis induced by elevated aortic pressure in rat heart.
Am. J. Physiol.
252 (Cell Physiol. 21):
C323-C327,
1987
10.
Cooper, G., IV.
Cardiocyte adaptation to chronically altered load.
Annu. Rev. Physiol.
49:
501-518,
1987[Medline].
11.
Corin, W. J.,
M. M. Swindle,
J. F. Spann, Jr.,
K. Nakano,
M. Frankis,
R. W. W. Biederman,
A. Smith,
A. Taylor,
and
B. A. Carabello.
Mechanism of decreased forward stroke volume in children and swine with ventricular septal defect and failure to thrive.
J. Clin. Invest.
82:
544-551,
1988.
12.
Cutilletta, A. F.,
M. Rudnik,
and
R. Zak.
Muscle and non-muscle cell RNA polymerase activity during the development of myocardial hypertrophy.
J. Mol. Cell. Cardiol.
10:
677-687,
1978[Medline].
13.
Grossman, W.,
D. Jones,
and
L. P. McLaurin.
Wall stress and patterns of hypertrophy in the human left ventricle.
J. Clin. Invest.
56:
56-64,
1975.
14.
Hannan, R. D.,
J. Luyken,
and
L. I. Rothblum.
Regulation of ribosomal DNA transcription during contraction-induced hypertrophy of neonatal cardiomyocytes.
J. Biol. Chem.
271:
3213-3220,
1996
15.
Hasegawa, K.,
S. J. Lee,
S. M. Jobe,
B. E. Markham,
and
R. N. Kitsis.
cis-Acting sequences that mediate induction of
-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction.
Circulation
96:
3943-3953,
1997
16.
Hershey, J. W. B.
Translational control in mammalian cells.
Annu. Rev. Biochem.
60:
717-755,
1991[Medline].
17.
Imamura, T.,
P. J. McDermott,
R. L. Kent,
M. Nagatsu,
G. Cooper IV,
and
B. A. Carabello.
Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload.
Circ. Res.
75:
418-425,
1994
18.
Ivester, C. T.,
R. L. Kent,
H. Tagawa,
H. Tsutsui,
T. Imamura,
G. Cooper IV,
and
P. J. McDermott.
Electrically stimulated contraction accelerates protein synthesis rates in adult feline cardiocytes.
Am. J. Physiol.
265 (Heart Circ. Physiol. 34):
H666-H674,
1993
19.
Ivester, C. T.,
W. J. Tuxworth,
G. Cooper IV,
and
P. J. McDermott.
Contraction accelerates myosin heavy chain synthesis rates in adult feline cardiocytes by an increase in the rate of translational initiation.
J. Biol. Chem.
270:
21950-21957,
1995
20.
Izumo, S.,
B. Nadal-Ginard,
and
V. Mahdavi.
Proto-oncogene induction and reprogramming of cardiac gene expression produced by pressure overload.
Proc. Natl. Acad. Sci. USA
85:
339-343,
1988
21.
Joshi, B.,
A. Cai,
B. D. Keiper,
W. B. Minich,
R. Mendez,
C. M. Beach,
J. Stepinski,
R. Stolarski,
E. Darzynkiewicz,
and
R. E. Rhoads.
Phosphorylation of eukaryotic protein synthesis initiation factor 4E at ser-209.
J. Biol. Chem.
270:
14597-14603,
1995
22.
Kent, R. L.,
and
P. J. McDermott.
Passive load and angiotensin II evoke differential responses of gene expression and protein synthesis in cardiac myocytes.
Circ. Res.
78:
829-838,
1996
23.
Koide, M.,
M. Nagatsu,
M. R. Zile,
M. Hamawaki,
M. M. Swindle,
G. Keech,
G. DeFreyte,
H. Tagawa,
G. Cooper IV,
and
B. A. Carabello.
Premorbid determinants of left ventricular dysfunction in a novel model of gradually induced pressure overload in the adult canine.
Circulation
95:
1601-1610,
1997
24.
Matsuo, T.,
B. A. Carabello,
Y. Nagatomo,
M. Koide,
M. Hamawaki,
M. R. Zile,
and
P. J. McDermott.
Mechanisms of cardiac hypertrophy in canine volume overload.
Am. J. Physiol.
275 (Heart Circ. Physiol. 44):
H65-H74,
1998
25.
McDermott, P. J.,
L. L. Carl,
K. J. Conner,
and
S. N. Allo.
Transcriptional regulation of ribosomal RNA synthesis during growth of cardiac myocytes in culture.
J. Biol. Chem.
266:
4409-4416,
1991
26.
McDermott, P. J.,
L. I. Rothblum,
S. D. Smith,
and
H. E. Morgan.
Accelerated rates of ribosomal RNA synthesis during growth of contracting heart cells in culture.
J. Biol. Chem.
264:
18220-18227,
1989
27.
Mezzetti, G. S.,
S. Ferrari,
P. Davalli,
R. Battini,
and
A. Corti.
Peptide chain initiation and analysis of in vitro translation products in rat heart undergoing hypertrophic growth.
J. Mol. Cell. Cardiol.
15:
629-635,
1983[Medline].
28.
Minich, W. B.,
M. L. Balasta,
D. J. Goss,
and
R. E. Rhoads.
Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form.
Proc. Natl. Acad. Sci. USA
91:
7668-7672,
1994
29.
Molkentin, J. D.,
S. M. Jobe,
and
B. E. Markham.
-Myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter.
J. Mol. Cell. Cardiol.
28:
1211-1225,
1996[Medline].
30.
Morgan, H. E.,
and
C. J. Beinlich.
Contributions of increased efficiency and capacity of protein synthesis to rapid cardiac growth.
Mol. Cell. Biochem.
176:
145-151,
1997[Medline].
31.
Morgan, H. E.,
E. E. Gordon,
Y. Kira,
B. H. L. Chua,
L. A. Russo,
C. J. Peterson,
P. J. McDermott,
and
P. A. Watson.
Biochemical mechanisms of cardiac hypertrophy.
Annu. Rev. Physiol.
49:
533-543,
1987[Medline].
32.
Nagai, R.,
R. B. Low,
W. S. Stirewalt,
N. R. Alpert,
and
R. Z. Litten.
Efficiency and capacity of protein synthesis are increased in pressure overload cardiac hypertrophy.
Am. J. Physiol.
255 (Heart Circ. Physiol. 24):
H325-H328,
1988
33.
Nakano, K.,
M. M. Swindle,
F. Spinale,
K. Ishihara,
S. Kanazawa,
A. Smith,
R. W. W. Biederman,
L. Clamp,
Y. Hamada,
M. R. Zile,
and
B. A. Carabello.
Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload.
J. Clin. Invest.
87:
2077-2086,
1991.
34.
Ojamaa, K.,
J. F. Petrie,
C. Balkman,
C. Hong,
and
I. Klein.
Posttranscriptional modification of myosin heavy-chain gene expression in the hypertrophied rat myocardium.
Proc. Natl. Acad. Sci. USA
91:
3468-3472,
1994
35.
Rackley, C. E.,
H. T. Dodge,
Y. D. Coble,
and
R. E. Hay.
A method for determining left ventricular mass in man.
Circulation
29:
666-671,
1964
36.
Rossi, A.,
J. Aussedut,
J. Olivares,
A. Ray,
and
M. Verdys.
Pyrimidine nucleotide metabolism in cardiac hypertrophy.
Eur. Heart J.
5, Suppl. F:
155-162,
1984.
37.
Siehl, D.,
B. H. L. Chua,
N. Lautensack-Belser,
and
H. E. Morgan.
Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of rat heart.
Am. J. Physiol.
248 (Cell Physiol. 17):
C309-C319,
1985
38.
Tagawa, H.,
J. D. Rozich,
H. Tsutsui,
T. Narishige,
D. Kuppuswamy,
H. Sato,
P. J. McDermott,
M. Koide,
and
G. Cooper IV.
Basis for increased microtubules in pressure hypertrophied cardiocytes.
Circulation
93:
1230-1243,
1996
39.
Umeda, P. K.,
D. S. Darling,
J. M. Kennedy,
S. Jakovcic,
and
R. Zak.
Control of myosin heavy chain expression in cardiac hypertrophy.
Am. J. Cardiol.
59:
49A-55A,
1987[Medline].
40.
Wada, H.,
C. T. Ivester,
B. A. Carabello,
G. Cooper IV,
and
P. J. McDermott.
Translational initiation factor eIF-4E. A link between cardiac load and protein synthesis.
J. Biol. Chem.
271:
8359-8364,
1996
41.
Wiesner, R. J.,
H. Ehmke,
J. Faulhaber,
R. Zak,
and
J. C. Rüegg.
Dissociation of left ventricular hypertrophy,
-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis.
Circulation
95:
1253-1259,
1997
This article has been cited by other articles:
![]() |
D. Scholz, C. F. Baicu, W. J. Tuxworth, L. Xu, H. Kasiganesan, D. R. Menick, and G. Cooper IV Microtubule-dependent distribution of mRNA in adult cardiocytes Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1135 - H1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Deschamps, K. A. Apple, A. H. Leonardi, J. E. McLean, W. M. Yarbrough, R. E. Stroud, L. L. Clark, J. A. Sample, and F. G. Spinale Myocardial Interstitial Matrix Metalloproteinase Activity Is Altered by Mechanical Changes in LV Load: Interaction With the Angiotensin Type 1 Receptor Circ. Res., May 27, 2005; 96(10): 1110 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Adams, V. J. Caiozzo, F. Haddad, and K. M. Baldwin Cellular and molecular responses to increased skeletal muscle loading after irradiation Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1182 - C1195. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |